Case Reports Using Continuous Glucose Monitoring: Analysis For Application Of Digitalization In Management Of Diabetes Mellitus
Life Sciences
DOI:
https://doi.org/10.22376/ijlpr.2023.13.4.SP6.L87-L99Keywords:
Type 1 Diabetes Mellitus, Type 2 Diabetic Mellitus, Estimated A1c, Continuous Glucose Monitoring, Innovative DM Management MethodAbstract
Diabetes has emerged as a burgeoning health challenge in the last two decades. Specifically, there is an alarming rate of adult-onset diabetes mellitus, a point of deep concern. Therefore, cohesive steps are essential for the management of symptoms of diabetes mellitus to regulate its prevalence rate globally. Continuous glucose monitoring (CGM) technology can aid in this effort by allowing for safe therapy intensification with HbA1c (hemoglobin-a1c) reduction and by assisting in lowering some of the psychosocial impacts of diabetes. We aim to analyze the application of the digital device Freestyle Libre Pro in the management of diabetes mellitus. Using the FreeStyle Libre Pro CGM system, we analyzed the datasets for eight patients over 14 days. In addition, regular 12-hour data was monitored on a fortnight basis. Two of the eight cases were on insulin, and the rest were administered oral medications for diabetes care. Ambulatory Glucose Profiles, Average Glucose Levels, Time in Range, Time Below Range, Time Above Range, and, afterward, calculation of HbA1c levels were determined for eight patients using the FreeStyle Libre Pro system's current glucose measurements. We observed that for four patients, the average glucose levels were maintained in range, and for f our patients, the average glucose levels were above range. Regarding Time, four were above range, and four were in range. Our analysis shows that the Freestyle Libre Pro offers an alternative to current CGM devices for professional use as it may aid clinics and patients.
References
World Health Organization (WHO). Global Report on Diabetes 2016; WHO: Geneva, Switzerland, 2016.
Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2011.
Wild, S.; Roglic, G.; Green, A.; Sicree, R.; King, H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27, 1047–1053.
Chase, H.P.; Beck, R.W.; Xing, D.; Tamborlane, W.V.; Coffey, J.; Fox, L.A.; Ives, B.; Keady, J.; Kollman, C.; Laffel, L.; et al. Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Technol. Ther. 2010, 12, 507–515.
Vigersky, R.A. The benefits, limitations, and cost-effectiveness of advanced technologies in managing patients with diabetes mellitus. J. Diabetes Sci. Technol. 2015, 9, 320–330.
Ehrhardt, N.M.; Chellappa, M.; Walker, M.S.; Fonda, S.J.; Vigersky, R.A. The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus. J. Diabetes Sci. Technol. 2011, 5, 668–675.
Clark, L.C.; Lyon, C. Electrode systems for continuous monitoring in cardiovascular surgery. Ann. N. Y. Acad. Sci. 1962, 102, 29–45.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183– 1197
Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P: Expert Committee on the Diagnosis and Classification of Diabetes Mellitus2, the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160– 3167
International Expert Committee International Expert Committee report on the role of the A1C assay in diagnosing diabetes. Diabetes Care 2009; 32: 1327– 1334
Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ: Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 2004; 19: 1175– 1180
Pradhan AD, Rifai N, Buring JE, Ridker PM: Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 2007; 120: 720– 727
Sato KK, Hayashi T, Harita N, Yoneda T, Nakamura Y, Endo G, Kambe H: Combined measurement of fasting plasma glucose and A1C effectively predicts type 2 diabetes: the Kansai Healthcare Study. Diabetes Care 2009; 32: 644– 646
Shimazaki T, Kadowaki T, Ohyama Y, Ohe K, Kubota K: Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital. Translational Research 2007; 149: 196– 204
Geiss LS, Pan L, Cadwell B, Gregg EW, Benjamin SM, Engelgau MM: Changes in incidence of diabetes in U.S. adults, 1997–2003. Am J Prev Med 2006; 30: 371– 377
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393– 403
Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E: the DESIR Study Group Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Diabetes Care 2006; 29: 1619– 1625
Carpenter MW, Coustan DR: Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144: 768– 773
O'Sullivan JB, Mahan CM: Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964; 13: 278.
HAPO Study Cooperative Research Group. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002
Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM, Jr, Sciscione A, Catalano P, Harper M, Saade G, Lain KY, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GB: Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361: 1339– 1348
Pfeiffer AF, Klein HH. The treatment of type 2 diabetes. Dtsch Arztebl Int. 2014 Jan 31;111(5):69-81; quiz 82. doi: 10.3238/arztebl.2014.0069. PMID: 24612534; PMCID: PMC3952010.
https://www.endocrine.org/patient-engagement/endocrine-library/diabetes-technology
Coss-Bu JA, Jefferson LS, Stone-McCord S, et al. Evaluation of a real-time blood glucose monitor in children with diabetic ketoacidosis. Diabetes Res Clin Pract 1999;44:175–81.
Lal RA, Maahs DM. Clinical Use of Continuous Glucose Monitoring in Pediatrics. Diabetes Technol Ther 2017;19:S37–S43.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study G, Fox LA, Beck RW, Xing D Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nondiabetic individuals. Diabetes Care 2010;33:1297–9.
Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomized controlled trial. Diabetologia 2012;55:3155–62.
Block JM. Continuous glucose monitoring: changing diabetes behavior in real-time and retrospectively. J Diabetes Sci Technol 2008;2:484–9.
Derosa G, Salvadeo SA, Mereu R, et al. Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study. Diabetes Technol Ther 2009;11:159–69.
Dovc K, Bratina N, Battelino T. A new horizon for glucose monitoring. Horm Res Paediatr 2015;83:149–56.
Edge J, Acerini C, Campbell F, et al. An alternative sensor-based method for glucose monitoring in children and young people with diabetes. Archives of disease in childhood 2017;102:543–9.
Kesavadev J, Shankar A, Ashok AD, et al. Our First 825 T2DM Patients on 14-Day Factory-Calibrated Glucose Monitoring System: Clinical Utility and Challenges. J Diabetes Sci Technol 2018;12:230–1.
Laffel L Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies. Diabetes Technol Ther 2016;18 Suppl 2:S223–33.
Palylyk-Colwell E, Ford C. Flash Glucose Monitoring System for Diabetes. CADTH Issues in Emerging Health Technologies; Ottawa (ON)2016:1–13.
Mauras N, Beck RW, Ruedy KJ, et al. Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study. J Pediatr 2004;144:770–5.
Mazze RS, Strock E, Wesley D, et al. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol Ther 2008;10:149–59.
Okada J, Yamada E, Saito T, Okada S, Yamada M. Variation of measured values associated with different lots of sensors for the FreeStyle Libre. J Diabetes 2018;10:986–7.
Rasbach LE, Volkening LK, Markowitz JT, Butler DA, Katz ML, Laffel LM. Youth and parent measures of self-efficacy for continuous glucose monitoring: survey psychometric properties. Diabetes Technol Ther 2015;17:327–34.
Zhou J, Li H, Ran X, et al. Reference values for continuous glucose monitoring in Chinese subjects. Diabetes Care 2009;32:1188–93.
Rai S, Hulse A, Kumar P. Feasibility and acceptability of ambulatory glucose profile in children with Type 1 diabetes mellitus: A pilot study. Indian J Endocrinol Metab 2016;20:790–4.
Deja G, Kleczek M, Chumiecki M, Strzala-Kleczek A, Deja R, Jarosz-Chobot P. The usefulness of the FlashStyle Libre system in glycemic control in children with type 1 diabetes during summer camp. Pediatr Endocrinol Diabetes Metab 2018;24:11–9.
Cengiz E, Tamborlane WV. A tale of two compartments: interstitial versus blood glucose monitoring. Diabetes Technol Ther 2009;11 Suppl 1:S11–6.
Cheyne EH, Cavan DA, Kerr D. Performance of a continuous glucose monitoring system during controlled hypoglycemia in healthy volunteers. Diabetes Technol Ther 2002;4:607–13.
Freckmann G, Link M, Pleus S, Westhoff A, Kamecke U, Haug C. Measurement Performance of Two Continuous Tissue Glucose Monitoring Systems Intended for Replacement of Blood Glucose Monitoring. Diabetes Technol Ther 2018;20:541–9.
Bailey T, Bode BW, Christiansen MP, Klaff LJ, Alva S. The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System. Diabetes Technol Ther 2015;17:787–94.
Rodbard D Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities. Diabetes Technol Ther 2016;18 Suppl 2:S3–S13.
Massa GG, Gys I, Op ’t Eyndt A, et al. Evaluation of the FreeStyle(R) Libre Flash Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes. Horm Res Paediatr 2018;89:189–99.
Szadkowska A, Gawrecki A, Michalak A, Zozulinska-Ziolkiewicz D, Fendler W, Mlynarski W. Flash Glucose Measurements in Children with Type 1 Diabetes in Real-Life Settings: To Trust or Not to Trust? Diabetes Technol Ther 2018;20:17–24.
Blum A. Freestyle Libre Glucose Monitoring System. Clin Diabetes. 2018 Apr; 36(2): 203–204. doi: 10.2337/cd17-0130
Beck RW, Bergenstal RM, Riddlesworth TD, et al. (2019) Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care 42: 400–5.
Park C., & Le Q. A. (2018). The effectiveness of continuous glucose monitoring in patients with type 2 diabetes: A systematic review of literature and meta-analysis. Diabetes Technology and Therapeutics, 20(9), 613–621. 10.1089/dia.2018.0177
Martens T. Beck R. W. Bailey R. Ruedy K. J. Calhoun P. Peters A. L. Pop-Busui R. Philis-Tsimikas A. Bao S. Umpierrez G. Davis G. Kruger D. Bhargava A. Young L. McGill J. B. Aleppo G. Nguyen Q. T. Orozco I. Biggs W. Lucas K. J. Polonsky W. H. Buse J. B. Price D., & Bergenstal R. M., & MOBILE Study Group. (2021). Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: A randomized clinical trial. Jsls: Journal of the Society of Laparoendoscopic Surgeons, 325(22), 2262–2272. 10.1001/jama.2021.7444
Heinemann L. Freckmann G. Ehrmann D. Faber-Heinemann G. Guerra S. Waldenmaier D., & Hermanns N. (2018). Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycemia awareness or severe hypoglycemia treated with multiple daily insulin injections (HypoDE): A multicentre, randomized controlled trial. Lancet, 391(10128), 1367–1377. 10.1016/S0140-6736(18)30297-6
Tauschmann M. Allen J. M. Wilinska M. E. Thabit H. Stewart Z. Cheng P. Kollman C. Acerini C. L. Dunger D. B., & Hovorka R. (2016). Day-and-night hybrid closed-loop insulin delivery in adolescents with type 1 diabetes: A free-living, randomized clinical trial. Diabetes Care, 39(7), 1168–1174. 10.2337/dc15-2078
Kröger J. Fasching P., & Hanaire H. (2020). Three European retrospective real-world chart review studies to determine the effectiveness of flash glucose monitoring on HbA1c in adults with type 2 diabetes. Diabetes Therapy, 11(1), 279–291. 10.1007/s13300-019-00741-9
Nana M. Moore S. L. Ang E. Lee Z. X., & Bondugulapati L. N. R. (2019). Flash glucose monitoring: Impact on markers of glycaemic control and patient-reported outcomes in individuals with type 1 diabetes mellitus in the real-world setting. Diabetes Research and Clinical Practice, 157, 107893. 10.1016/j.diabres.2019.107893
Gilbert T. R. Noar A. Blalock O., & Polonsky W. H. (2021). Change in hemoglobin A1c and quality of life with real-time continuous glucose monitoring use by people with insulin-treated diabetes in the landmark study. Diabetes Technology and Therapeutics, 23(Suppl 1), S35–S39. 10.1089/dia.2020.0666
Tyndall V. Stimson R. H. Zammitt N. N. Ritchie S. A. McKnight J. A. Dover A. R., & Gibb F. W. (2019). Marked improvement in HbA. Diabetologia, 62(8), 1349–1356. 10.1007/s00125-019-4894-1
Hásková A. Radovnická L. Petruželková L. Parkin C. G. Grunberger G. Horová E. Navrátilová V. Kádě O. Matoulek M. Prázný M., & Šoupal J. (2020). Real-time CGM is superior to flash glucose monitoring for glucose control in type 1 diabetes: The CORRIDA randomized controlled trial. Diabetes Care, 43(11), 2744–2750. 10.2337/dc20-0112
Reddy M., Jugnee N., Anantharaja S., & Oliver N. (2018a). Switching from flash glucose monitoring to continuous glucose monitoring on hypoglycemia in adults with type 1 diabetes at high hypoglycemia risk: The extension phase of the I HART CGM study. Diabetes Technology and Therapeutics, 20(11), 751–757. 10.1089/dia.2018.0252
Reddy M., Jugnee N. El Laboudi A., Spanudakis E., Anantharaja S., & Oliver N. (2018b). A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with type 1 diabetes and impaired awareness of hypoglycemia. Diabetic Medicine: a Journal of the British Diabetic Association, 35(4), 483–490. 10.1111/dme.13561
Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R. Novel glucose-sensing technology and hypoglycemia in type 1 diabetes: a multicentre, non-masked, randomized controlled trial. Lancet. 2016;388:2254–63. https://doi.org/10.1016/S0140-6736(16)31535-5.
Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline J-P, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8:55–73. https://doi.org/10.1007/s13300-016-0223-6.Epub2016Dec20.
Campbell FM, Murphy NP, Stewart C, Biester T, Kordonouri O. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study. Pediatr Diabetes. 2018;19:1294–301.
Roussel R, Riveline J-P, Vicaut E, et al. Important drop rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in France: The RELIEF Study. Diabetes Care. 2021;dc201690.
Deshmukh H, Wilmot EG, Gregory R, et al. Effect of flash glucose monitoring on glycemic control, hypoglycemia, diabetes-related distress, and resource utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit. Diabetes Care. 2020;43:2153–60.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Rajesh Saxena, Dr. Anurupa B Singh, Dr. N. P .Singh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
